Ward 21 CRS (31966)
Welcome,         Profile    Billing    Logout  
 0 Trials 
6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Dadabhai, Sufia
PALISADE, NCT06134362: Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Recruiting
3
3500
RoW
CAB LA, Apretude, CAB LA for PrEP
ViiV Healthcare, GlaxoSmithKline, PPD DEVELOPMENT, LP
HIV Infections
06/28
06/28
CoVPN3008, NCT05168813: Efficacy Study of COVID-19 mRNA Vaccine in Regions With SARS-CoV-2 Variants of Concern

Completed
2/3
14232
RoW
Moderna mRNA-1273, Vaccine 3 Dose, Vaccine 2 Dose
COVID-19 Prevention Network, National Institute of Allergy and Infectious Diseases (NIAID), Medical Research Council, South Africa
SARS-CoV-2 Infection, HIV Infections, COVID-19
04/24
04/24
PAUSE, NCT06031272: Pausing Antiretroviral Treatment Under Structured Evaluation

Recruiting
1
48
RoW
3BNC117-LS-J, 10-1074-LS-J, Placebo for 3BNC117-LS-J, Placebo for 10-1074-LS-J
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, National Institute of Allergy and Infectious Diseases (NIAID)
HIV-1-infection
06/25
06/26
NCT03878147: Neurodevelopmental Assessment of Children in Uganda and Malawi Using a Software Package

Active, not recruiting
N/A
600
RoW
Cognitive Games Training, Brain Powered Games, Village Builder
Michigan State University, University of Michigan, Johns Hopkins University, MU-JHU CARE, Kamuzu University of Health Sciences, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
HIV Infections, HIV Exposed Uninfected, HUU Unexposed Uninfected
02/24
12/25
Mathew, Carrie-Anne
PALISADE, NCT06134362: Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)

Recruiting
3
3500
RoW
CAB LA, Apretude, CAB LA for PrEP
ViiV Healthcare, GlaxoSmithKline, PPD DEVELOPMENT, LP
HIV Infections
06/28
06/28
PAUSE, NCT06031272: Pausing Antiretroviral Treatment Under Structured Evaluation

Recruiting
1
48
RoW
3BNC117-LS-J, 10-1074-LS-J, Placebo for 3BNC117-LS-J, Placebo for 10-1074-LS-J
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, National Institute of Allergy and Infectious Diseases (NIAID)
HIV-1-infection
06/25
06/26

Download Options